Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Sironax logo — Pioneering breakthroughs in treating age-related degenerativ...

Sironax

Pioneering breakthroughs in treating age-related degenerative diseases to enhance the quality of life for millions globally.

Founded 2017 51-200 employees Series B Total: $301.00M Biotechnology, Health Care +2

General Information

Company Name Sironax
Founded Year 2017
Employees 51-200
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Sironax. To contact Sironax, visit sironax.com.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Sironax

Sironax is a biotechnology company that aims to revolutionize the treatment of age-related degenerative diseases, ultimately improving the quality of life for millions worldwide. Founded in 2017 and based in Beijing, China, the company is currently at the clinical stage, focusing on developing innovative therapies targeting regulated cell death, neuroprotective pathways, and neuroinflammation. Its recent Series B investment of $200.00M on 02 August 2022 has attracted a diverse group of investors including Eight Roads Ventures, F-Prime Capital, Gaorong Capital, Invus, Temasek Holdings, CBC Group, Superstring Capital, Future Innovation Fund, YF Capital, and K2 Venture Capital. Sironax's ambitious goals and significant backing position it as an influential player in the biotechnology and healthcare industries, with the potential to make a profound impact on global healthcare.

Taxonomy: clinical-stage, age-related degenerative diseases, regulated cell death, neuroprotective pathways, neuroinflammation, treatment development, innovation, quality of life, Beijing, China, neurosciences, inflammatory diseases

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $200.00M 10
Eight Roads Ventures F-Prime Capital Gaorong Capital
Eight Roads Ventures, F-Prime Capital +8
02 Aug 2022
Series A $101.00M -
01 Sep 2019
Seed Round Undisclosed -
01 Jun 2018

Sironax Alternatives & Competitors

View All Alternatives
Sironax vs
Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. United States

Advancing Accessible Solutions for Complex Neurodegenerative Diseases

IPO
29 employees
Biotechnology, Health Care
Sironax vs
Tetralogic Pharmaceuticals
Tetralogic Pharmaceuticals

TetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused on d...

Convertible Note
10 employees
Biotechnology, Health Care
Sironax vs
Refoxy Pharma
Refoxy Pharma Germany

Discovering medicines to treat age-related diseases and extend the years of healthy living

Seed
4 employees
Health and Wellness, Manufacturing
View all alternatives

FAQ About Sironax

Pioneering breakthroughs in treating age-related degenerative diseases to enhance the quality of life for millions globally.
Sironax was founded in 2017.
Sironax operates in Biotechnology, Health Care, Health and Wellness and Pharmaceutical. Its work centres on clinical-stage, age-related degenerative diseases, regulated cell death and neuroprotective pathways.
Sironax has approximately 51-200 employees.
Sironax has completed 3 funding rounds, raising a total of $301.00M. The latest funding stage is Series B.
Top alternatives and competitors to Sironax include Cognition Therapeutics, Inc., Tetralogic Pharmaceuticals, Refoxy Pharma, Lineage Cell Therapeutics, Allakos Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sironax and Cognition Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sironax, https://bouncewatch.com/company/sironax, updated 18 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes